Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bevan

Showing results (111-120 of 826) with videos related to

Pageof 83
Sort By:
Immunity|January 1, 1995
T cell receptor antagonists and partial agonistsS C Jameson, M J Bevan
Cell|April 16, 2004
Driven to autoimmunity: the nod mouseAlena M Gallegos, Michael J Bevan
The Journal of Experimental Medicine|June 1, 1982
Helper T cells for cytotoxic T lymphocytes need not be I region restrictedD H Raulet, M J Bevan
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Cells infected with Yersinia present an epitope to class I MHC-restricted CTLM N Starnbach, M J Bevan
The Journal of the Royal College of General Practitioners. Occasional Paper|December 1, 1979
Doctors on the moveJ Bevan, D Cunningham, C Floyd
Current Opinion in Immunology|April 10, 2010
From the thymus to longevity in the peripheryLinda M Wakim, Michael J Bevan
Thrombosis Research|July 15, 1989
Verapamil is a potent inhibitor of 5-HT-induced platelet aggregationE Glusa, J Bevan, S Heptinstall
European Journal of Immunology|June 1, 1987
Mutual tolerization of histoincompatible lymphocytesH G Rammensee, M J Bevan
Nature|April 2, 2011
Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infectionLinda M Wakim, Michael J Bevan
The Journal of Experimental Medicine|January 1, 1982
Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesisT R Hünig, M J Bevan
Pageof 83

Showing results (111-120 of 826) with videos related to

Sort By:
Pageof 83
Immunity|January 1, 1995
T cell receptor antagonists and partial agonistsS C Jameson, M J Bevan
Cell|April 16, 2004
Driven to autoimmunity: the nod mouseAlena M Gallegos, Michael J Bevan
The Journal of Experimental Medicine|June 1, 1982
Helper T cells for cytotoxic T lymphocytes need not be I region restrictedD H Raulet, M J Bevan
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Cells infected with Yersinia present an epitope to class I MHC-restricted CTLM N Starnbach, M J Bevan
The Journal of the Royal College of General Practitioners. Occasional Paper|December 1, 1979
Doctors on the moveJ Bevan, D Cunningham, C Floyd
Current Opinion in Immunology|April 10, 2010
From the thymus to longevity in the peripheryLinda M Wakim, Michael J Bevan
Thrombosis Research|July 15, 1989
Verapamil is a potent inhibitor of 5-HT-induced platelet aggregationE Glusa, J Bevan, S Heptinstall
European Journal of Immunology|June 1, 1987
Mutual tolerization of histoincompatible lymphocytesH G Rammensee, M J Bevan
Nature|April 2, 2011
Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infectionLinda M Wakim, Michael J Bevan
The Journal of Experimental Medicine|January 1, 1982
Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesisT R Hünig, M J Bevan
Pageof 83